BOULDER, Colo., Aug. 27, 2025 /PRNewswire/ — BranchLab, the AI-native healthcare technology company redefining how health brands reach and engage patients, today announced the appointment of Dan Parkes as Chief Technology Officer. Parkes will lead BranchLab’s engineering, AI, and data science teams as the company expands its outcome-based platform for privacy-first audience design, omnichannel activation, and health outcomes measurement.
Parkes brings over two decades of technical and leadership experience, having built and scaled advanced systems at pioneering companies including Placecast, Ericsson, and Amazon. His expertise lies in architecting enterprise-grade platforms that derive actionable insights from complex, multimodal data, making him uniquely positioned to accelerate BranchLab’s mission of transforming healthcare marketing to positively impact health outcomes.
“Dan’s background sits exactly at the intersection of regulated data, AI, and enterprise infrastructure, precisely where BranchLab operates at scale,” said Josh Walsh, CEO of BranchLab. “His leadership will be critical as we continue to advance a privacy-safe, AI-native platform that delivers real-world outcomes for patients and providers.”
BranchLab’s platform enables healthcare brands and their media partners to define, activate, and measure predictive audiences using non-health data, while ensuring compliance with evolving state and federal privacy regulations. By blending de-identified health claims data, public health datasets, and predictive AI, the platform identifies and targets non-health audience segments most likely to achieve meaningful outcomes such as prescriptions, diagnoses, or healthcare visits.
“What drew me to BranchLab is the clarity of the product vision and the real-world urgency of the mission,” said Parkes. “Healthcare deserves the precision of modern AI paired with a deep respect for privacy. I’m excited to help scale the technology that’s already making that possible.”
Parkes will report directly to CEO Josh Walsh and lead all aspects of platform engineering, infrastructure, and AI innovation.
About BranchLab
BranchLab is an AI-native technology company setting a new standard in privacy-first, outcome-based advertising for healthcare. Its platform enables brands, agencies, and media partners to design, activate, and measure audiences optimized to real-world outcomes such as prescriptions, diagnoses, or healthcare visits using non-health data. BranchLab operates in the United States with offices in New York, Colorado and San Francisco.
For more information, please contact: press@branchlab.com
SOURCE BranchLab Inc
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…